VOYA Investment Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$469K Buy
58,373
+24,245
+71% +$232K ﹤0.01% 1743
2025
Q4
$398K Sell
34,128
-80,725
-70% -$785K ﹤0.01% 1850
2025
Q3
$1.15M Sell
114,853
-51,331
-31% -$737K ﹤0.01% 1433
2025
Q2
$2.9M Buy
166,184
+100,461
+153% +$1.45M ﹤0.01% 1156
2025
Q1
$827K Sell
65,723
-1,554
-2% -$18.7K ﹤0.01% 1650
2024
Q4
$710K Buy
67,277
+19,381
+40% +$271K ﹤0.01% 1782
2024
Q3
$694K Buy
47,896
+30,589
+177% +$364K ﹤0.01% 1824
2024
Q2
$147K Buy
+17,307
New +$154K ﹤0.01% 2566
2021
Q2
Sell
-5,350
Closed -$233K 2892
2021
Q1
$233K Buy
+5,350
New +$253K ﹤0.01% 2450

Other funds holding SPRY